Pazufloxacin mesilate
CAS: 136905-87-8
Rif. 3D-FP104088
25g | Fuori produzione | ||
50g | Fuori produzione | ||
100g | Fuori produzione | ||
250g | Fuori produzione | ||
500g | Fuori produzione |
Informazioni sul prodotto
- Pazufloxacin Mesilate
- (3S)-10-(1-Aminocyclopropyl)-9-Fluoro-2,3-Dihydro-3-Methyl-7-Oxo-7H-Pyrido[1,2,3-De]-1,4-Benzoxazine-6-Carboxylic Acid Methanesulfonate
- T 3762
- Pasil
- Pazucross
- Pazufloxacin Methanesulfonate
- (S)-(-)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid monomethanesulfonate
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, monomethanesulfonate (9CI)
- Pazufloxacin Mesylate
- (3S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid methanesulfonate
- Vedi altri sinonimi
Pazufloxacin mesilate is a fluoroquinolone antibiotic that inhibits bacterial growth by binding to the 50S ribosomal subunit. It is used in the treatment of urinary tract infections, as well as other infectious diseases such as sepsis, pneumonia, and chronic bronchitis. Pazufloxacin mesilate has been shown to have a synergistic effect with glucose injection, which may be due to its ability to bind to human serum proteins. The drug also interacts with drugs like phenytoin and phenobarbital that are metabolized through cytochrome P450 enzymes. This interaction can lead to drug toxicity or decreased efficacy.